Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Change-To-Liabilities" stands at 3.29 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 37.98 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 37.98 Billion Japanese Yens.
The 3 year change is 41.17 Billion Japanese Yens.
The 5 year change is -49.28 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change To Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change To Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Change To Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Change To Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change To Liabilities | 280,205,508,085.11 |